Alzheimer’s disease Aging and Health National Institute for Longevity Sciences, Japan Neuroscience Research Institute, Peking University Department of.

Slides:



Advertisements
Similar presentations
Epidemiology of Dementia
Advertisements

Measuring the Burden of Musculoskeletal Disease Musculoskeletal Conditions and Injuries: Status and Goals United States Bone and Joint Decade.
HOW CAN NEUROIMAGING HELP UNDERSTAND, DIAGNOSE, AND DEVELOP TREATMENTS FOR ALZHEIMER'S DISEASE? Part D2 – AD brain scans – metabolism - PET NUCLEAR MEDICINE.
Epidemiological study of mild cognitive impairment and pilot evaluation of methods of early dementia detection in Chinese community Yueqin Huang MD MPH.
Partnering across borders to effect change Glasgow – 3 June 2013 Jean Georges, Executive Director.
Frontotemporal Dementia
The Future of Neuroscience Premier Health Partners / Wright State University Neuroscience Institute.
Chapter 9. Older Persons Striving to maintain their health Undergoing rehab Struggling dementia.
Helena Chui, M.D. McCarron Professor and Chair of Neurology Director, Alzheimer Disease Research Center.
Epidemiology of Dementia in Canada: Information from the Canadian Study of Health and Aging.
The Burden of Chronic Diseases in Missouri: Opportunities and Challenges for Public Health Shumei Yun, MD, PhD Chronic Disease Public Health Epidemiologist.
Recreational Therapy: An Introduction Chapter 9: Geriatric Practice PowerPoint Slides.
HOW CAN NEUROIMAGING HELP UNDERSTAND, DIAGNOSE, AND DEVELOP TREATMENTS FOR ALZHEIMER'S DISEASE? Part A – AD definition, neuropath? NUCLEAR MEDICINE GRAND.
Indianapolis Discovery Network for Dementia Forecasting the Future Impact of Early Detection and Management Program for Alzheimer.
COGNITIVE ASSESSMENT IN THE ELDERLY PATIENT Jennifer Breznay, MD, MPH Division of Geriatrics Department of Medicine Maimonides Medical Center November.
Canadian Study of Health and Aging Disability and Frailty.
Activity Report ILC-Japan Cape Town, Oct. 25, 2010.
The Healthy Body, Healthy Brain Campaign Alaska Commission on Aging Alaska Division of Public Health Alaska Mental Health Trust Legislative Health Caucus.
Non-medication Management of Agitated Behavior in Dementia Patients Josepha A. Cheong, MD University of Florida Departments of Psychiatry and Neurology.
Initial presentation of multiple sclerosis in northern Iran; Is there any comparison to other countries Initial presentation of multiple sclerosis in northern.
CI-1 Exelon ® (rivastigmine) United States Food and Drug Administration Peripheral and Central Nervous System Drugs Advisory Committee May 17, 2006.
Alzheimer’s Disease Landscape
Mild Cognitive Impairment
Alzheimer’s Society, UK Our research programme
1 A follow up study of mild cognitive impairment in Beijing ----finding from 10/66 study Zhaorui Liu, Chuanjun Zhuo, Yueqin Huang, Shuran Li, Institute.
Economic Value of Family Caregiving: 2004 Peter S. Arno, PhD Department of Epidemiology and Population Health Montefiore Medical Center Albert Einstein.
By OPAL & Memory Team Improving the Individual Experience – Getting the System Right EARLY DIAGNOSIS INTEGRATED CARE PATHWAY RBCH Model.
Nearly 5 Million Americans Have CHF 400,000 new onset cases diagnosed annually 1400,000 new onset cases diagnosed annually 1 Over 250,000 deaths annually.
“3 D’s” of Geriatrics Dementia, Delirium, and Depression These common disorders can look alike. GAI often helps uncover or differentiate them. All are.
CU-1 Summary of Neuropathological and Clinical Features of PDD Clive Ballard, MD Professor of Age Related Diseases Institute of Psychiatry King’s College.
6/22/2004 Complexities Co-occurring Disorders-Li final-1 Ting-Kai Li, M.D. Director National Institute on Alcohol Abuse and Alcoholism National.
Epidemiological and Pharmacoeconomic Aspects of Alzheimer‘s Disease and Dementia.
Joint Finance Committee Hearing FY 2013 Susan Del Pesco Division Director February 21, 2012 Department of Health and Social Services Division of Long Term.
Peripheral and Central Nervous System Drugs Advisory Committee Meeting - March 14, Issues Related to the Development of Drugs for the Treatment.
Alcohol Abuse and Alcoholism in China Jian-Hui Liang MD, Ph.D National Institute on Drug Dependence Peking University, Beijing, , P.R.China.
张瀚哲 Hanzhe Zhang 5-Year Program in Clinical Medicine Second Military Medical University PM2.5 Impairs Our Brain & Heart
Health social system in China Lian Tong Doctoral student (D3) Sep 29, 2010 Lab of International Community Care and Lifespan Development.
Canadian Study of Health and Aging The Prevalence of Dementia 1991 Baseline Study.
Health Determinants, Measurements, and Trends
CS-1 Regulatory Considerations: PDD Indication for Exelon ® (rivastigmine) Martina Struck, PhD Senior Associate Director Drug Regulatory Affairs Novartis.
Update and Thank you to participants Bradley Hyman MD PhD Director, Mass ADRC ViceChair, Neurology, Massachusetts General Hospital.
The role of Nutrition in Geriatric Mental Health Chih-Chiang Chiu, M.D., Ph.D. Department of Psychiatry, Taipei City Psychiatric Center.
Comparison of Risk Factors for Early-Onset versus Late-Onset Alzheimer Disease OBJECTIVE To compare early-onset (before 65) Alzheimer disease (AD) patients.
Design of a Research Study on the influence of the Household Model in nursing homes Mark Morgan-Brown Dympna Manley Marcus Ormerod Rita Newton SURFACE.
Date of download: 6/23/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Dementia Subtypes in China: Prevalence in Beijing,
Adopting a Holistic Approach to Resident Wellness It’s All About Living Life to the Fullest Joan Devine, RN-BC Director of Performance Improvement Lutheran.
Dement Geriatr Cogn Disord 2011;31:239– DOI: /
M. M. Dumitru¹∙², V.Chirita¹∙², R.Chirita¹∙²
Increasing Prevalence of Diabetes Over Time
Epidemiology: Assignment 3
Effect of centrally acting ACE inhibitors on Alzheimer’s disease progress: A retrospective longitudinal study using SLAM BRC Case register Dr Gayan Perera.
Dement Geriatr Cogn Disord Extra 2014;4: DOI: /
Seizures in Alzheimer’s disease
Clinical Spectrum, Risk Factors, and Behavioral Abnormalities among Dementia Subtypes in a North Indian Population: A Hospital-Based Study Dement Geriatr.
Figure 3 Life expectancy at birth in all countries included
Cognitive Disorders and Aging
Best Practices to Simplify and Optimize
Volume 382, Issue 9902, Pages (October 2013)
John F. Crary, MD-PhD Associate Professor
Systematic Review and Meta-Analysis of Combination Therapy with Cholinesterase Inhibitors and Memantine in Alzheimer’s Disease and Other Dementias Dement.
Volume 381, Issue 9882, Pages (June 2013)
Volume 382, Issue 9902, Pages (October 2013)
Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic.
University of Washington, Seattle, WA
Psychiatric Nursing: Theory, Principles, and Trends
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Current status of maintenance hemodialysis in Beijing, China
Dementia and Cerebrovascular Disease
Dementia in Africa: Focus on Nigeria
Fig. 1. ROC curve for K-IADL to diagnose dementia or MCI
Presentation transcript:

Alzheimer’s disease Aging and Health National Institute for Longevity Sciences, Japan Neuroscience Research Institute, Peking University Department of Neurology, Third Hospital of Peking University Norman Bethune Fund Cognitive Disorder Fund Committee (Director) CODATA and IAUD* Joint Internet Forum: Dialogue Between Scientists and Designers - Beijing and Kyoto Prof. Dehua Chui MD, PhD

Growth in U.S. Population Aged 65+, 75+, and 85+ Source: U.S. Census Bureau DH Chui incidence

World prevalence of dementia 1 25million people in the world with dementia Double every 20 years 40 million by million by Ferri C, Prince M, Brayne C, Brodaty H et al, Lancet 2005 DH Chui

World prevalence of dementia 1 Age  60 years: 1.26% AD 0.74%VaD AD prevalence: 2.10% F 0.76% M VaD prevalence: 0.71% F 0.69% M 1 Liu L et al, Dement Geriatr Cogn Disor, 2003

Age % 23.97%

Burden of the Society caused by AD Prevalence ( the cost paid by the society and the family of the patients ) 4,500,000 AD patients in U.S. > 6,000,000 AD patients in China > 20,000,000 AD, PD patients in China in the year of AD patient /4-6 person/family/ 85Y life span (mean) ~20,000 dollars/year/patient U.S. ~100,000,000,000 dollars/year U.S. 10,000 RMB/year/patient CHN 60,000,000,000 RMB/year CHN 200,000,000,000 RMB /year in 2050 ( AD , PD ) CHN

Planning in Aging Society Dementia 35% Healthy 65% AD Diagnose For aged people AD Therapy fMRI /PET Cholinergic inhibitors BACE inhibitors Vaccination Chinese medicines Food business Clothes fashion House designing Robot service In 90-year-old people

Supporting Aging Society

Thank You!